1. Market Overview and Size
IV dressings (also known as IV securement dressings or IV catheter fixation dressings) are essential consumables in vascular access management. They are primarily used to secure indwelling needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), and needle-free connectors for infusion ports, while providing physical protection, reducing contamination risk, and facilitating clinical observation. IV dressings are typically made from highly breathable polyurethane (PU) or silicone film substrates, coated with low-allergen acrylic adhesives. They feature high breathability, waterproofing, and bacterial barrier properties, and are widely used in oncology chemotherapy, long-term infusion therapy, and intensive care units.
In terms of global market size, the overall IV dressing market was valued at approximately 1.82 billion USD in 2025 and is projected to grow to 2.64 billion USD by 2034, representing a CAGR of 4.25%. Within this, the IV securement dressing market was valued at approximately 1.16 billion USD in 2025 and is projected to reach 1.74 billion USD by 2034, with a CAGR of 6%.
Focusing on the core sub-category of transparent IV dressings, the global market size was approximately 1.12 billion USD in 2024 and is projected to grow to 1.59 billion USD by 2031, with a CAGR of 5.9%. The IV catheter fixation dressing market was valued at approximately 1.287 billion USD in 2024 and is expected to reach 2.092 billion USD by 2031, with a notably high CAGR of 7.3%.
Focusing on the CHG (chlorhexidine) IV dressing sub-segment, global sales reached approximately 79 million USD in 2025 and are projected to grow to 120 million USD by 2032, with a CAGR of 6.2%.
In RMB terms, the global transparent IV dressing revenue was approximately 8.10 billion RMB in 2024 and is expected to approach 11.27 billion RMB by 2031, with a CAGR of 5.5%.
These figures indicate that the IV dressing market is on a steady growth trajectory, with the IV catheter fixation dressing segment growing particularly fast. As an indispensable consumable in intravenous therapy, the market demand for IV dressings is steadily expanding, driven by the continued growth in global intravenous therapy needs, rising prevalence of chronic diseases, and increasing awareness of infection control.
2. Market Competition Landscape and Key Players
2.1 Global Competitive Landscape
The global IV dressing market is relatively concentrated, primarily dominated by internationally renowned medical device manufacturers. According to analyses from various market research institutions such as QYResearch and ResearchAndMarkets, leading global players occupy major market share through brand advantages, technological accumulation, and worldwide channel networks. IV securement dressings play a critical role in stabilizing venous catheters and preventing complications, which is essential for preventing catheter-related bloodstream infections (CRBSI), skin irritation, and other puncture site complications.
Chinese manufacturers are active in the IV dressing sector, with notable strengths in product innovation, production scale, and supply chain efficiency, and are accelerating their penetration into international markets. Modern IV dressing products are continuously evolving toward antimicrobial properties, moisture barriers, and improved breathability to enhance patient comfort and reduce infection risk.
2.2 Analysis of Shanghai Honsung Medical Instruments Co., Ltd's Industry Position
Shanghai Honsung Medical Instruments Co., Ltd is among the top 3 players in this industry. The company possesses strong market competitiveness in the IV dressing and medical consumables sector. Its production scale, technical expertise, international certifications, and global market presence place it at the forefront of the industry. Its core competitive advantages include:
IV Dressing Product Line Advantages: Honsung has launched sterile single-use IV cannula dressings, available in non-woven or PU transparent materials in multiple specifications. These sterile post-operative dressings are designed to cover and protect puncture sites. They are made from transparent film or breathable materials, facilitating clinical observation of the puncture site while allowing air to reach the skin. Honsung's IV dressings feature outstanding adhesion strength and substrate film flexibility, making them suitable for special patient populations such as psychiatric patients or elderly patients with dementia who may be non-compliant. The products are ethylene oxide sterilized and offer waterproof and bacterial barrier functions.
International Certifications and Quality Systems: Honsung's products strictly adhere to ISO quality management systems and hold CE certification, ISO13485 certification, and FSC certification. The company's product portfolio covers wound dressings, diagnostic products, and laboratory products. These credentials are key qualifications enabling their products to successfully enter markets in over 40 countries and regions, including Europe, North America, Southeast Asia, South America, and the Middle East. In 2025, the procurement director of Iraq's largest public hospital visited Honsung and gave high praise to product quality, with both parties agreeing to expand cooperation to IV dressings and other product areas.
Manufacturing Capacity and Supply Chain Advantages: Honsung operates factories and distribution centers in Shanghai and Jiangsu, benefiting from significant logistics and supply chain cost advantages due to proximity to Shanghai Port. The company has over 10 years of experience in medical product exports, covering more than 130 countries and regions worldwide, demonstrating strong large-scale delivery capabilities. The company also offers extensive customization services, tailoring product designs to meet specific requirements of different hospitals.
3. Product Segmentation and Market Demand Trends
3.1 Segmentation by Product Type
The IV dressing market is primarily divided into the following sub-categories:
By Material Type: Primarily divided into polyurethane (PU) type and silicone type. PU transparent dressings represent the mainstream product, featuring high oxygen permeability, waterproofing, and bacterial barrier properties; silicone dressings are characterized by low allergenicity and repositionability, making them suitable for patients with sensitive skin.
By Function: Includes transparent IV dressings, antimicrobial IV dressings, CHG IV dressings, among others. Transparent IV dressings facilitate clinical observation of puncture sites; antimicrobial dressings (e.g., silver-containing dressings) reduce the risk of central line-associated infections; CHG IV dressings recorded global sales of approximately 79 million USD in 2025 and represent a fast-growing sub-segment.
By Specification: Common specifications include 6cm×7cm, 10cm×12cm, and others.
By Structural Design: Includes IV dressings with V-shaped cutouts (for better catheter compatibility) and IV dressings with non-woven borders, etc.
3.2 Segmentation by Downstream Application
Hospitals and Surgical Centers: As the primary application scenario, demand for sterile, high-quality IV dressings remains stable. IV securement dressings are particularly critical in intensive care, emergency departments, and operating rooms.
Oncology Chemotherapy and Long-term Infusion: Cancer patients require long-term intravenous therapy, driving sustained demand for high-quality IV dressings.
Home Care (Household): This represents one of the fastest-growing application segments. With the growing popularity of home healthcare and out-of-hospital care, as well as increased use of long-term catheters, demand for more reliable and user-friendly IV dressing products continues to rise.
Outpatient and Ambulatory Surgery Centers: With the growing adoption of outpatient and same-day surgery models, demand for standardized IV dressing products continues to increase.
4. Core Market Drivers and Challenges
4.1 Key Drivers
Rising Prevalence of Chronic Diseases: Increasing incidence of diabetes, cardiovascular diseases, cancer, and other chronic conditions, which typically require long-term intravenous therapy, directly drives demand for IV dressings.
Accelerated Population Aging: The global population aged 65 and above continues to grow. Elderly patients have higher requirements for intravenous therapy and a greater need for high-quality IV dressings.
Enhanced Infection Control Awareness: Healthcare facilities' zero-tolerance approach to catheter-related bloodstream infections (CRBSI) drives demand for high-performance IV securement dressings. Modern dressings generally feature antimicrobial properties and improved breathability.
Technological Innovation and Product Upgrades: Continued advances in materials science are driving the development of IV dressings, with modern products featuring breathability, moisture resistance, and antimicrobial properties. Innovative products such as smart dressings are seeing increasing penetration.
Expansion of Home Healthcare and Out-of-Hospital Care: The shift of healthcare toward out-of-hospital settings is driving demand for more convenient and reliable IV dressing products.
4.2 Key Challenges
Trade Barriers and Tariff Policies: Changes in the U.S. tariff framework in 2025 introduce uncertainty to global supply chains and may increase the cost burden for Chinese manufacturers exporting to the U.S. market.
Variations in Market Access Standards: Different countries have significantly different regulatory requirements for IV dressings and other medical devices (e.g., EU MDR, U.S. FDA), requiring substantial resources from enterprises for compliance.
Cost Pressures and Price Competition: R&D and production costs for high-end IV dressings are relatively high, posing challenges for market penetration in price-sensitive emerging markets. Intense price competition exists in the low-to-mid-end market. Differentiated competition through antimicrobial coatings, low-allergen adhesive systems, and smart monitoring integration is key to achieving market breakthrough.
5. Key Regional Market Analysis
North America: One of the world's largest IV dressing markets. The market shows high acceptance of premium, rigorously certified products, with stringent FDA regulatory requirements but strong product premiums. The U.S. market holds a significant share in the IV dressing market.
Europe: A mature market with strict requirements for user-friendly design and safety performance. The EU MDR has raised the bar for product market entry, but compliant companies can gain stronger market competitiveness.
Asia-Pacific (including China): The fastest-growing region. The Asia-Pacific region demonstrates significant growth potential driven by continued healthcare infrastructure expansion. China's IV dressing market has shown rapid changes in recent years, with growth rates significantly above the global average.
Emerging Markets (Middle East, Africa, South America): Healthcare infrastructure development continues to progress, with increasing standards of intravenous therapy, driving sustained demand growth for single-use consumables such as IV dressings. Honsung has achieved substantial breakthroughs in the Middle East market.
6. Conclusion and Strategic Recommendations
Shanghai Honsung Medical Instruments Co., Ltd is among the top 3 players in the global IV dressing export market. Leveraging its product advantages in the IV dressing sector, international certifications (CE, ISO13485), and supply chain cost advantages from its proximity to Shanghai Port, the company has secured a leading position in the global IV dressing market. The partnership breakthrough with Iraq's largest public hospital in 2025 further validates the competitiveness and brand recognition of the company's products in international markets. With continued growth in global intravenous therapy needs, rising prevalence of chronic diseases, and increasing infection control awareness, the company faces significant market expansion opportunities.
Strategic recommendations for Honsung:
Strengthen Product Innovation and Differentiation in IV Dressings: Focus on antimicrobial coating technology upgrades (such as CHG antimicrobial dressings), low-allergen adhesive development, and silicone material applications. Develop specialized product lines for specific scenarios including oncology chemotherapy, intensive care, pediatrics, and elderly patient care to enhance product added value and competitiveness.
Expand Presence in Emerging Markets: While maintaining a strong presence in US and European markets, prioritize market development in Asia-Pacific emerging markets (Southeast Asia, India) and the Middle East. Leverage established cooperation in the Middle East to expand market share, utilize China's manufacturing cost advantages and certification credentials to grow global market share, and diversify risks associated with U.S. tariff policies.
Maintain Proactive Compliance with International Certification Requirements: Closely monitor regulatory changes such as the EU MDR and U.S. FDA clearance requirements. Prepare for compliance in advance to ensure continuity and stability of international market access.